Home › Funds › Two Sigma Investments › FATE
Two Sigma Investments position in FATE
FATE THERAPEUTICS INC · Health Care
Latest position (Q2 2026)3.59M sh
Reported value held$9.69M
Portfolio Weight0.01%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 299.54K | $17.75M | New |
| Q4 2021 | 14.70K | $860.00K | Reduce |
| Q3 2022 | 189.07K | $4.24M | New |
| Q4 2022 | 1.50M | $15.17M | Add |
| Q1 2023 | 1.80M | $10.28M | Add |
| Q2 2023 | 1.92M | $9.13M | Add |
| Q3 2023 | 1.65M | $3.50M | Reduce |
| Q4 2023 | 1.55M | $5.80M | Reduce |
| Q1 2024 | 265.00K | $1.95M | Reduce |
| Q2 2024 | 1.02M | $3.35M | Add |
| Q3 2024 | 459.56K | $1.61M | Reduce |
| Q4 2024 | 297.11K | $490.23K | Reduce |
| Q1 2025 | 241.87K | $191.10K | Reduce |
| Q2 2025 | 228.41K | $255.81K | Reduce |
| Q3 2025 | 900.76K | $1.13M | Add |
| Q4 2025 | 1.73M | $1.70M | Add |
| Q1 2026 | 3.47M | $4.16M | Add |
| Q2 2026 | 3.59M | $9.69M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding FATE
- BlackRock Inc 7.30M sh · $19.71M · Q2 2026
- AQR Capital Management 3.84M sh · $10.36M · Q2 2026
- Vanguard Group 8.97M sh · $8.82M · Q4 2025
- Renaissance Technologies 2.98M sh · $8.05M · Q2 2026
- Millennium Management 2.43M sh · $6.57M · Q2 2026
- Goldman Sachs Group 2.05M sh · $5.53M · Q2 2026
- Geode Capital Management 1.32M sh · $3.57M · Q2 2026
- Citadel Advisors 1.09M sh · $2.95M · Q2 2026
- Morgan Stanley 694.58K sh · $1.88M · Q2 2026
- Charles Schwab Investment Management 610.95K sh · $1.65M · Q2 2026
- UBS Group AG 590.18K sh · $1.59M · Q2 2026